SciSparc: Subsidiary NeuroThera Labs Pursues FDA Orphan Drug Designation For Adult Tourette Syndrome Drug; Engages Government and Public Affairs Firm RK Strategies

FDA Orphan Drug pursuit signals regulatory milestone; government affairs engagement adds strategic catalyst.